Peter Kies - 26 Feb 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: CFO
Signature: /s/ Peter Kies
Issuer symbol: INO
Transactions as of: 26 Feb 2026
Net transactions value: -$16,574
Form type: 4
Filing time: 27 Feb 2026, 16:48:27 UTC
Previous filing: 21 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
KIES PETER	CFO	C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE ROAD, SAN DIEGO	/s/ Peter Kies	27 Feb 2026	0001259780

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+5,010	+17%		35,267	26 Feb 2026	Direct	F1
transaction	INO	Common Stock	Tax liability	$5,307	-2,965	-8.4%	$1.79	32,302	26 Feb 2026	Direct	F2
transaction	INO	Common Stock	Options Exercise		+10,634	+33%		42,936	26 Feb 2026	Direct	F3
transaction	INO	Common Stock	Tax liability	$11,266	-6,294	-15%	$1.79	36,642	26 Feb 2026	Direct	F4
holding	INO	Common Stock						375	26 Feb 2026	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-5,010	-50%	$0.000000	5,009	26 Feb 2026	Common Stock	5,010		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-10,634	-33%	$0.000000	21,266	26 Feb 2026	Common Stock	10,634		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.